BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16217039)

  • 1. Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL).
    Fukuda R; Hayashi A; Utsunomiya A; Nukada Y; Fukui R; Itoh K; Tezuka K; Ohashi K; Mizuno K; Sakamoto M; Hamanoue M; Tsuji T
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15213-8. PubMed ID: 16217039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-cell leukemia virus type I tax down-regulates the expression of phosphatidylinositol 3,4,5-trisphosphate inositol phosphatases via the NF-kappaB pathway.
    Fukuda RI; Tsuchiya K; Suzuki K; Itoh K; Fujita J; Utsunomiya A; Tsuji T
    J Biol Chem; 2009 Jan; 284(5):2680-2689. PubMed ID: 19047050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AILIM/ICOS-mediated elongation of activated T cells is regulated by both the PI3-kinase/Akt and Rho family cascade.
    Nukada Y; Okamoto N; Konakahara S; Tezuka K; Ohashi K; Mizuno K; Tsuji T
    Int Immunol; 2006 Dec; 18(12):1815-24. PubMed ID: 17077177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide phosphatases: just as important as the kinases.
    Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
    Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-I Tax regulates the cellular proliferation through the down-regulation of PIP3-phosphatase expressions via the NF-κB pathway.
    Fukuda RI; Tsuchiya K; Suzuki K; Itoh K; Fujita J; Utsunomiya A; Tsuji T
    Int J Biochem Mol Biol; 2012; 3(1):95-104. PubMed ID: 22509484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
    Ohshima K
    Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
    Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
    Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.
    Miletic AV; Anzelon-Mills AN; Mills DM; Omori SA; Pedersen IM; Shin DM; Ravetch JV; Bolland S; Morse HC; Rickert RC
    J Exp Med; 2010 Oct; 207(11):2407-20. PubMed ID: 20956547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes.
    Harris SJ; Parry RV; Westwick J; Ward SG
    J Biol Chem; 2008 Feb; 283(5):2465-9. PubMed ID: 18073217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential association of phosphatidylinositol 3-kinase, SHIP-1, and PTEN with forming phagosomes.
    Kamen LA; Levinsohn J; Swanson JA
    Mol Biol Cell; 2007 Jul; 18(7):2463-72. PubMed ID: 17442886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
    Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
    Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell signaling modifiers for molecular targeted therapy in ATLL.
    Mori N
    Front Biosci (Landmark Ed); 2009 Jan; 14(4):1479-89. PubMed ID: 19273141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
    Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
    Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.
    Kozako T; Yoshimitsu M; Fujiwara H; Masamoto I; Horai S; White Y; Akimoto M; Suzuki S; Matsushita K; Uozumi K; Tei C; Arima N
    Leukemia; 2009 Feb; 23(2):375-82. PubMed ID: 18830259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Eur J Pharmacol; 2020 Apr; 872():172953. PubMed ID: 31996318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of the T cell quiescence factor KLF2 in a leukaemic T-cell line after expression of the inositol 5'-phosphatase SHIP-1.
    García-Palma L; Horn S; Haag F; Diessenbacher P; Streichert T; Mayr GW; Jücker M
    Br J Haematol; 2005 Dec; 131(5):628-31. PubMed ID: 16351639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound heterozygosity for Pten and SHIP augments T-dependent humoral immune responses and cytokine production by CD(4+) T cells.
    Moody JL; Jirik FR
    Immunology; 2004 Jul; 112(3):404-12. PubMed ID: 15196208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.
    Nakagawa M; Schmitz R; Xiao W; Goldman CK; Xu W; Yang Y; Yu X; Waldmann TA; Staudt LM
    J Exp Med; 2014 Dec; 211(13):2497-505. PubMed ID: 25488980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of SHIP1 in T-lymphocyte life and death.
    Gloire G; Erneux C; Piette J
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):277-80. PubMed ID: 17371259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.